Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Autoimmune Disorders

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 248 articles:
HTML format



Single Articles


    September 2021
  1. WERTH VP, Joly P, Chen DM
    Rituximab versus Mycophenolate Mofetil in Pemphigus Vulgaris. Reply.
    N Engl J Med. 2021;385:1056.
    PubMed    


  2. HOPKINS ZH, Wu BC, Nousari CH
    Rituximab versus Mycophenolate Mofetil in Pemphigus Vulgaris.
    N Engl J Med. 2021;385:1055-1056.
    PubMed    


  3. BOLTON-MAGGS PHB, George JN
    Immune Thrombocytopenia Treatment.
    N Engl J Med. 2021;385:948-950.
    PubMed    


  4. BRADBURY CA, Pell J, Hill Q, Bagot C, et al
    Mycophenolate Mofetil for First-Line Treatment of Immune Thrombocytopenia.
    N Engl J Med. 2021;385:885-895.
    PubMed     Abstract available


    August 2021
  5. GOYAL RK
    Gastric Emptying Abnormalities in Diabetes Mellitus. Reply.
    N Engl J Med. 2021;385:576.
    PubMed    


  6. AKTURK HK, Shah VN
    Gastric Emptying Abnormalities in Diabetes Mellitus.
    N Engl J Med. 2021;385:575-576.
    PubMed    


  7. MOUGIAKAKOS D, Kronke G, Volkl S, Kretschmann S, et al
    CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus.
    N Engl J Med. 2021;385:567-569.
    PubMed    


    July 2021
  8. SMIBERT OC, Catalano OA, Goodarzi K, Roberts MB, et al
    Case 23-2021: A 41-Year-Old Woman with Bloody Stools and Thrombocytopenia.
    N Engl J Med. 2021;385:451-460.
    PubMed    


  9. KRATKA A, Yozamp N, Vaidya A, Marqusee E, et al
    A Periodic Problem.
    N Engl J Med. 2021;385:e17.
    PubMed    


  10. AVELAR RODRIGUEZ D, Orkin J
    An Icteric Tongue.
    N Engl J Med. 2021;385:e16.
    PubMed    


  11. MORAN-THOMAS A
    One Hundred Years of Insulin for Some.
    N Engl J Med. 2021;385:293-295.
    PubMed    


  12. GOGLIN SE, Margaretten ME
    Malar Rash.
    N Engl J Med. 2021;385:164.
    PubMed    


  13. PATRIQUIN CJ, Laroche V, Selby R, Pendergrast J, et al
    Therapeutic Plasma Exchange in Vaccine-Induced Immune Thrombotic Thrombocytopenia.
    N Engl J Med. 2021 Jul 7. doi: 10.1056/NEJMc2109465.
    PubMed    


    June 2021
  14. O'CONNELL KA, LaChance AH
    Dermatomyositis.
    N Engl J Med. 2021;384:2437.
    PubMed    


  15. SEEKER P, Osswald S
    Tongue Discoloration.
    N Engl J Med. 2021;384:e102.
    PubMed    


  16. WERTH VP, Joly P, Mimouni D, Maverakis E, et al
    Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus Vulgaris.
    N Engl J Med. 2021;384:2295-2305.
    PubMed     Abstract available


    May 2021
  17. JAYNE DRW, Merkel PA, Bekker P
    Avacopan for the Treatment of ANCA-Associated Vasculitis. Reply.
    N Engl J Med. 2021;384:e81.
    PubMed    


  18. MATSUO Y, Miyabe Y
    Avacopan for the Treatment of ANCA-Associated Vasculitis.
    N Engl J Med. 2021;384:e81.
    PubMed    


  19. CHANDWAR K
    Avacopan for the Treatment of ANCA-Associated Vasculitis.
    N Engl J Med. 2021;384:e81.
    PubMed    


  20. BLANCO-DOMINGUEZ R, Sanchez-Diaz R, de la Fuente H, Jimenez-Borreguero LJ, et al
    A Novel Circulating MicroRNA for the Detection of Acute Myocarditis.
    N Engl J Med. 2021;384:2014-2027.
    PubMed     Abstract available


  21. GIBBONS MD, Mendoza DP, Waheed A, Barshak MB, et al
    Case 14-2021: A 64-Year-Old Woman with Fever and Pancytopenia.
    N Engl J Med. 2021;384:1849-1857.
    PubMed    


  22. FRALICK M, Sarma S
    Thyrotoxic Periodic Paralysis.
    N Engl J Med. 2021;384:e71.
    PubMed    


  23. MOHAMED F, Raal FJ
    Hyperpigmentation from Addison's Disease.
    N Engl J Med. 2021;384:1752.
    PubMed    


    April 2021
  24. KOREN D, Sparger KA, Shailam R, Sadow PM, et al
    Case 13-2021: A Newborn Girl with a Neck Mass.
    N Engl J Med. 2021;384:1647-1655.
    PubMed    


  25. GREINACHER A, Thiele T, Warkentin TE, Weisser K, et al
    Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.
    N Engl J Med. 2021 Apr 9. doi: 10.1056/NEJMoa2104840.
    PubMed     Abstract available


  26. SCHULTZ NH, Sorvoll IH, Michelsen AE, Munthe LA, et al
    Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
    N Engl J Med. 2021 Apr 9. doi: 10.1056/NEJMoa2104882.
    PubMed     Abstract available


  27. ROTH A, Barcellini W, D'Sa S, Miyakawa Y, et al
    Sutimlimab in Cold Agglutinin Disease.
    N Engl J Med. 2021;384:1323-1334.
    PubMed     Abstract available


  28. ZONOZI R, Niles JL
    Sunken Nose.
    N Engl J Med. 2021;384:e52.
    PubMed    


    March 2021
  29. BUTLER PC
    Supplying Insulin while Evading Immunity.
    N Engl J Med. 2021;384:967-969.
    PubMed    


    February 2021
  30. WARRINGTON KJ
    Avacopan - Time to Replace Glucocorticoids?
    N Engl J Med. 2021;384:664-665.
    PubMed    


  31. JAYNE DRW, Merkel PA, Schall TJ, Bekker P, et al
    Avacopan for the Treatment of ANCA-Associated Vasculitis.
    N Engl J Med. 2021;384:599-609.
    PubMed     Abstract available


  32. GOVERMAN JM
    Regulatory T Cells in Multiple Sclerosis.
    N Engl J Med. 2021;384:578-580.
    PubMed    


  33. WU C, Dai R
    Central Retinal Artery and Vein Occlusion.
    N Engl J Med. 2021;384:e9.
    PubMed    


    January 2021
  34. ZAMVIL SS, Hauser SL
    Antigen Presentation by B Cells in Multiple Sclerosis.
    N Engl J Med. 2021;384:378-381.
    PubMed    


  35. FURIE R, Rovin BH, Roth DA
    Belimumab in Lupus Nephritis. Reply.
    N Engl J Med. 2021;384:188.
    PubMed    


  36. SCHONERMARCK U, Kemmner S, Fischereder M
    Belimumab in Lupus Nephritis.
    N Engl J Med. 2021;384:187-188.
    PubMed    


  37. ROJAS-RIVERA J, Ortiz A, Carriazo S
    Belimumab in Lupus Nephritis.
    N Engl J Med. 2021;384:187.
    PubMed    


  38. ANDERSON MS, Chaimowitz NS, Forbes LR
    More on STAT1 Gain of Function, Type 1 Diabetes, and JAK Inhibition. Reply.
    N Engl J Med. 2021;384:93-94.
    PubMed    


  39. JOHNSON MB, Hattersley AT, Patel KA
    More on STAT1 Gain of Function, Type 1 Diabetes, and JAK Inhibition.
    N Engl J Med. 2021;384:93.
    PubMed    


    December 2020
  40. LEVY-LAHAD E, King MC
    Hiding in Plain Sight - Somatic Mutation in Human Disease.
    N Engl J Med. 2020;383:2680-2682.
    PubMed    


  41. BECK DB, Ferrada MA, Sikora KA, Ombrello AK, et al
    Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease.
    N Engl J Med. 2020;383:2628-2638.
    PubMed     Abstract available


  42. BRETON MD, Beck RW, Wadwa RP
    A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes. Reply.
    N Engl J Med. 2020;383:2484.
    PubMed    


  43. FERNANDES N
    A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes.
    N Engl J Med. 2020;383:2484.
    PubMed    


  44. FAJGENBAUM DC, June CH
    Cytokine Storm.
    N Engl J Med. 2020;383:2255-2273.
    PubMed    


    November 2020
  45. ADANG L, Goldbach-Mansky R, Vanderver A
    JAK Inhibition in the Aicardi-Goutieres Syndrome. Reply.
    N Engl J Med. 2020;383:2191-2193.
    PubMed    


  46. NEVEN B, Al Adba B, Hully M, Desguerre I, et al
    JAK Inhibition in the Aicardi-Goutieres Syndrome.
    N Engl J Med. 2020;383:2190-2191.
    PubMed    


  47. ACCILI D
    Whither Type 1 Diabetes?
    N Engl J Med. 2020;383:2078-2079.
    PubMed    


  48. QUATTRIN T, Haller MJ, Steck AK, Felner EI, et al
    Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes.
    N Engl J Med. 2020;383:2007-2017.
    PubMed     Abstract available


  49. CAPLAN DN, Rapalino O, Karaa A, Rosovsky RP, et al
    Case 35-2020: A 59-Year-Old Woman with Type 1 Diabetes Mellitus and Obtundation.
    N Engl J Med. 2020;383:1974-1983.
    PubMed    


  50. CHOI B, Choudhary MC, Regan J, Sparks JA, et al
    Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host.
    N Engl J Med. 2020 Nov 11. doi: 10.1056/NEJMc2031364.
    PubMed    


    October 2020
  51. CORTAZAR FB, Rhee EP, Gupta S, Sakhuja R, et al
    Case 34-2020: A 74-Year-Old Man with Chronic Kidney Disease.
    N Engl J Med. 2020;383:1768-1778.
    PubMed    


  52. PLATTON S, Bowles L, Pasi KJ
    Lupus Anticoagulant in Patients with Covid-19. Reply.
    N Engl J Med. 2020;383.
    PubMed    


  53. GOODING R, Myers B, Salta S
    Lupus Anticoagulant in Patients with Covid-19.
    N Engl J Med. 2020;383.
    PubMed    


  54. FERNANDEZ-PRADO R, Ortiz A, Perez-Gomez MV
    Allopurinol and Chronic Kidney Disease.
    N Engl J Med. 2020;383:1690.
    PubMed    


  55. MCCORMICK N, Zhang Y, Choi HK
    Allopurinol and Chronic Kidney Disease.
    N Engl J Med. 2020;383:1689-1690.
    PubMed    


  56. CONWAY R
    Allopurinol and Chronic Kidney Disease.
    N Engl J Med. 2020;383:1689.
    PubMed    


  57. PONTICELLI C, Podesta MA
    Allopurinol and Chronic Kidney Disease.
    N Engl J Med. 2020;383:1688-1689.
    PubMed    


  58. KANG DH, Sanchez-Lozada LG, Johnson RJ
    Allopurinol and Chronic Kidney Disease.
    N Engl J Med. 2020;383:1687-1688.
    PubMed    


  59. GO JR, Abu Saleh OM
    Vancomycin-Induced Linear IgA Bullous Dermatosis.
    N Engl J Med. 2020;383:1577.
    PubMed    


  60. MIZUSHIMA N, Levine B
    Autophagy in Human Diseases.
    N Engl J Med. 2020;383:1564-1576.
    PubMed    


  61. OH JY
    Autoimmune Keratitis after Atezolizumab Treatment.
    N Engl J Med. 2020;383:1468.
    PubMed    


  62. CHAIMOWITZ NS, Ebenezer SJ, Hanson IC, Anderson M, et al
    STAT1 Gain of Function, Type 1 Diabetes, and Reversal with JAK Inhibition.
    N Engl J Med. 2020;383:1494-1496.
    PubMed    


    September 2020
  63. WANG G, Li H, Yang X, Guo T, et al
    Guillain-Barre Syndrome Associated with JEV Infection.
    N Engl J Med. 2020;383:1188-1190.
    PubMed    


  64. WARD M, Tektonidou MG
    Belimumab as Add-on Therapy in Lupus Nephritis.
    N Engl J Med. 2020;383:1184-1185.
    PubMed    


  65. OSTENDORF L, Burns M, Durek P, Heinz GA, et al
    Targeting CD38 with Daratumumab in Refractory Systemic Lupus Erythematosus.
    N Engl J Med. 2020;383:1149-1155.
    PubMed     Abstract available


  66. FURIE R, Rovin BH, Houssiau F, Malvar A, et al
    Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis.
    N Engl J Med. 2020;383:1117-1128.
    PubMed     Abstract available


  67. BLUESTONE JA, Anderson M
    Tolerance in the Age of Immunotherapy.
    N Engl J Med. 2020;383:1156-1166.
    PubMed    


  68. TRAPNELL BC, Inoue Y, Bonella F, Morgan C, et al
    Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis.
    N Engl J Med. 2020 Sep 7. doi: 10.1056/NEJMoa1913590.
    PubMed     Abstract available


  69. VANDERVER A, Adang L, Gavazzi F, McDonald K, et al
    Janus Kinase Inhibition in the Aicardi-Goutieres Syndrome.
    N Engl J Med. 2020;383:986-989.
    PubMed    


    August 2020
  70. BRETON MD, Kanapka LG, Beck RW, Ekhlaspour L, et al
    A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes.
    N Engl J Med. 2020;383:836-845.
    PubMed     Abstract available


  71. MUELLER AA, Vaidya A, Tarter LL, Klein JP, et al
    Caught in a Flare.
    N Engl J Med. 2020;383:e48.
    PubMed    


  72. HAUSER SL, Bar-Or A, Cohen JA, Comi G, et al
    Ofatumumab versus Teriflunomide in Multiple Sclerosis.
    N Engl J Med. 2020;383:546-557.
    PubMed     Abstract available


    July 2020
  73. WU K
    Uncertain Trust.
    N Engl J Med. 2020;383:204-205.
    PubMed    


  74. NISHIOKA R, Kawano M
    Tongue Ulceration from Cytomegalovirus Infection.
    N Engl J Med. 2020;383:67.
    PubMed    


  75. GAY E
    Blame.
    N Engl J Med. 2020;383:9.
    PubMed    


    June 2020
  76. FEIG DI
    Urate-Lowering Therapy and Chronic Kidney Disease Progression.
    N Engl J Med. 2020;382:2567-2568.
    PubMed    


  77. BADVE SV, Pascoe EM, Tiku A, Boudville N, et al
    Effects of Allopurinol on the Progression of Chronic Kidney Disease.
    N Engl J Med. 2020;382:2504-2513.
    PubMed     Abstract available


  78. DORIA A, Galecki AT, Spino C, Pop-Busui R, et al
    Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes.
    N Engl J Med. 2020;382:2493-2503.
    PubMed     Abstract available


  79. VICO-ALONSO C, Palencia-Perez S
    Linear IgA Bullous Dermatosis.
    N Engl J Med. 2020;382:2248.
    PubMed    


    May 2020
  80. WALSH M, Merkel PA, Jayne DRW
    Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis. Reply.
    N Engl J Med. 2020;382:2169.
    PubMed    


  81. ESPOSITO P, Cipriani L, Viazzi F
    Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis.
    N Engl J Med. 2020;382:2168-2169.
    PubMed    


  82. SEXTON DJ
    Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis.
    N Engl J Med. 2020;382:2168.
    PubMed    


  83. DOUGLAS RS, Kahaly GJ
    Teprotumumab for Active Thyroid Eye Disease. Reply.
    N Engl J Med. 2020;382:1959-1960.
    PubMed    


  84. ROOS JCP, Hyry HI, Murthy R
    Teprotumumab for Active Thyroid Eye Disease.
    N Engl J Med. 2020;382:1959.
    PubMed    


  85. KIM S, Patzek S
    Teprotumumab for Active Thyroid Eye Disease.
    N Engl J Med. 2020;382:1958-1959.
    PubMed    


  86. BOWLES L, Platton S, Yartey N, Dave M, et al
    Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19.
    N Engl J Med. 2020 May 5. doi: 10.1056/NEJMc2013656.
    PubMed    


    April 2020
  87. SOBRIN L, Stone JH, Huang AJ, Niles JL, et al
    Case 14-2020: A 37-Year-Old Man with Joint Pain and Eye Redness.
    N Engl J Med. 2020;382:1750-1758.
    PubMed    


  88. MORAND EF, Furie RA
    Anifrolumab in Systemic Lupus Erythematosus. Reply.
    N Engl J Med. 2020;382:1666.
    PubMed    


  89. PUTMAN M
    Anifrolumab in Systemic Lupus Erythematosus.
    N Engl J Med. 2020;382:1665-1666.
    PubMed    


  90. LUNDQUIST AL, Kalim S, Mojtahed A, Tomaszewski KJ, et al
    Case 13-2020: A 29-Year-Old Man with High Blood Pressure, Renal Insufficiency, and Hematuria.
    N Engl J Med. 2020;382:1639-1647.
    PubMed    


  91. TOSCANO G, Palmerini F, Ravaglia S, Ruiz L, et al
    Guillain-Barre Syndrome Associated with SARS-CoV-2.
    N Engl J Med. 2020 Apr 17. doi: 10.1056/NEJMc2009191.
    PubMed    


  92. ZULFIQAR AA, Lorenzo-Villalba N, Hassler P, Andres E, et al
    Immune Thrombocytopenic Purpura in a Patient with Covid-19.
    N Engl J Med. 2020 Apr 15. doi: 10.1056/NEJMc2010472.
    PubMed    


    March 2020
  93. COOPER N, Ghanima W
    Immune Thrombocytopenia. Reply.
    N Engl J Med. 2020;382:1077-1078.
    PubMed    


  94. NOHRIA V, Macie AC
    Immune Thrombocytopenia.
    N Engl J Med. 2020;382:1077.
    PubMed    


  95. SOCAL MP, Greene JA
    Interchangeable Insulins - New Pathways for Safe, Effective, Affordable Diabetes Therapy.
    N Engl J Med. 2020;382:981-983.
    PubMed    


  96. BELLO F, Fagni F
    Nasal Deformity in Granulomatosis with Polyangiitis.
    N Engl J Med. 2020;382:951.
    PubMed    


    February 2020
  97. DEREBAIL VK, Falk RJ
    ANCA-Associated Vasculitis - Refining Therapy with Plasma Exchange and Glucocorticoids.
    N Engl J Med. 2020;382:671-673.
    PubMed    


  98. WALSH M, Merkel PA, Peh CA, Szpirt WM, et al
    Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis.
    N Engl J Med. 2020;382:622-631.
    PubMed     Abstract available


  99. KOVATCHEV BP, Brown SA, Beck RW
    Multicenter Trial of Closed-Loop Control in Type 1 Diabetes. Reply.
    N Engl J Med. 2020;382:578.
    PubMed    


  100. ZUNIGA-HERNANDEZ JA, Medrano-De Avila C, Rodriguez-Gutierrez R
    Multicenter Trial of Closed-Loop Control in Type 1 Diabetes.
    N Engl J Med. 2020;382:577-578.
    PubMed    


  101. TAKITA M
    Multicenter Trial of Closed-Loop Control in Type 1 Diabetes.
    N Engl J Med. 2020;382:577.
    PubMed    


    January 2020
  102. DOUGLAS RS, Kahaly GJ, Patel A, Sile S, et al
    Teprotumumab for the Treatment of Active Thyroid Eye Disease.
    N Engl J Med. 2020;382:341-352.
    PubMed     Abstract available


  103. SALMON JE, Niewold TB
    A Successful Trial for Lupus - How Good Is Good Enough?
    N Engl J Med. 2020;382:287-288.
    PubMed    


  104. AZAR MM, Muse VV, Villalba JA, Turbett SE, et al
    Case 2-2020: A 64-Year-Old Man with Fever and Respiratory Failure.
    N Engl J Med. 2020;382:276-285.
    PubMed    


  105. FASANO A, Leonard MM, Mitchell DM, Eng G, et al
    Case 1-2020: An 11-Year-Old Boy with Vomiting and Weight Loss.
    N Engl J Med. 2020;382:180-189.
    PubMed    


    December 2019
  106. MORAND EF, Furie R, Tanaka Y, Bruce IN, et al
    Trial of Anifrolumab in Active Systemic Lupus Erythematosus.
    N Engl J Med. 2019 Dec 18. doi: 10.1056/NEJMoa1912196.
    PubMed     Abstract available


    November 2019
  107. YAMAMURA T, Kleiter I, Fujihara K, Palace J, et al
    Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder.
    N Engl J Med. 2019;381:2114-2124.
    PubMed     Abstract available


  108. BRODSKY RA
    Warm Autoimmune Hemolytic Anemia. Reply.
    N Engl J Med. 2019;381:1881-1882.
    PubMed    


  109. SHVIDEL L, Stanevsky A, Sigler E
    Warm Autoimmune Hemolytic Anemia.
    N Engl J Med. 2019;381:1881.
    PubMed    


  110. HEROLD KC, Bundy BN, Krischer JP
    Teplizumab in Relatives at Risk for Type 1 Diabetes. Reply.
    N Engl J Med. 2019;381:1880-1881.
    PubMed    


  111. KORSGREN O, Skog O, Ludvigsson J
    Teplizumab in Relatives at Risk for Type 1 Diabetes.
    N Engl J Med. 2019;381:1879-1880.
    PubMed    


  112. COURI CE, Malmegrim KCR, Oliveira MC
    Teplizumab in Relatives at Risk for Type 1 Diabetes.
    N Engl J Med. 2019;381:1879.
    PubMed    


  113. ILANY J
    Teplizumab in Relatives at Risk for Type 1 Diabetes.
    N Engl J Med. 2019;381:1879.
    PubMed    


  114. SMITH C, Dhaliwal G, Saint S, Farkash EA, et al
    Double Trouble.
    N Engl J Med. 2019;381:1854-1860.
    PubMed    


    October 2019
  115. BRUTTOMESSO D
    Toward Automated Insulin Delivery.
    N Engl J Med. 2019;381:1774-1775.
    PubMed    


  116. FERVENZA FC, Cattran DC
    Rituximab or Cyclosporine for Membranous Nephropathy. Reply.
    N Engl J Med. 2019;381:1689-1690.
    PubMed    


  117. PONTICELLI C, Moroni G
    Rituximab or Cyclosporine for Membranous Nephropathy.
    N Engl J Med. 2019;381:1688-1689.
    PubMed    


  118. WALDMAN M, Austin HA 3rd, Balow JE
    Rituximab or Cyclosporine for Membranous Nephropathy.
    N Engl J Med. 2019;381:1688.
    PubMed    


  119. VALOTI E, Noris M, Remuzzi G
    More about Factor H Autoantibodies in Membranous Nephropathy.
    N Engl J Med. 2019;381:1590-1592.
    PubMed    


  120. LI J, Zhou Z
    Calcinosis in Juvenile Dermatomyositis.
    N Engl J Med. 2019;381:e31.
    PubMed    


  121. CHWALISZ BK, Buchbinder BR, Schmahmann JD, Samore WR, et al
    Case 32-2019: A 70-Year-Old Woman with Rapidly Progressive Ataxia.
    N Engl J Med. 2019;381:1569-1578.
    PubMed    


  122. BROWN SA, Kovatchev BP, Raghinaru D, Lum JW, et al
    Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes.
    N Engl J Med. 2019 Oct 16. doi: 10.1056/NEJMoa1907863.
    PubMed     Abstract available


  123. TUNKEL AR, Baron EL, Buch KA, Marty FM, et al
    Case 31-2019: A 45-Year-Old Woman with Headache and Somnolence.
    N Engl J Med. 2019;381:1459-1470.
    PubMed    


  124. MUSSO D, Ko AI, Baud D
    Zika Virus Infection - After the Pandemic.
    N Engl J Med. 2019;381:1444-1457.
    PubMed    


    September 2019
  125. SHARMA K, Patel A
    Livedo Reticularis in Cold Agglutinin Disease.
    N Engl J Med. 2019;381:e27.
    PubMed    


  126. COOPER N, Ghanima W
    Immune Thrombocytopenia.
    N Engl J Med. 2019;381:945-955.
    PubMed    


  127. TAZAWA R, Ueda T, Abe M, Tatsumi K, et al
    Inhaled GM-CSF for Pulmonary Alveolar Proteinosis.
    N Engl J Med. 2019;381:923-932.
    PubMed     Abstract available


    August 2019
  128. BRODSKY RA
    Warm Autoimmune Hemolytic Anemia.
    N Engl J Med. 2019;381:647-654.
    PubMed    


  129. PITTOCK SJ, Berthele A, Fujihara K, Kim HJ, et al
    Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder.
    N Engl J Med. 2019;381:614-625.
    PubMed     Abstract available


  130. CHIAPPA V, Anderson MA, Barrett CD, Stathatos N, et al
    Case 24-2019: A 39-Year-Old Woman with Palpitations, Abdominal Pain, and Vomiting.
    N Engl J Med. 2019;381:567-577.
    PubMed    


  131. CHARROW A, Vleugels RA
    Cutaneous Ulcerations in Anti-MDA5 Dermatomyositis.
    N Engl J Med. 2019;381:465.
    PubMed    


    July 2019
  132. CHEN Z, Wang X, Ye S
    Tofacitinib in Amyopathic Dermatomyositis-Associated Interstitial Lung Disease.
    N Engl J Med. 2019;381:291-293.
    PubMed    


  133. FREEMAN MW, Singh AK, Guidon AC, Arvikar SL, et al
    Case 22-2019: A 65-Year-Old Woman with Weakness, Dark Urine, and Dysphagia.
    N Engl J Med. 2019;381:275-283.
    PubMed    


  134. DEUTSCHER S
    Phage Display to Detect and Identify Autoantibodies in Disease.
    N Engl J Med. 2019;381:89-91.
    PubMed    


  135. RUGGENENTI P, Remuzzi G
    A First Step toward a New Approach to Treating Membranous Nephropathy.
    N Engl J Med. 2019;381:86-88.
    PubMed    


  136. FERVENZA FC, Appel GB, Barbour SJ, Rovin BH, et al
    Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy.
    N Engl J Med. 2019;381:36-46.
    PubMed     Abstract available


  137. LEE I, Walker JB, Nozaki K, Willett LL, et al
    Weak and Winded.
    N Engl J Med. 2019;381:76-82.
    PubMed    


    June 2019
  138. ROSEN CJ, Ingelfinger JR
    Traveling down the Long Road to Type 1 Diabetes Mellitus Prevention.
    N Engl J Med. 2019 Jun 9. doi: 10.1056/NEJMe1907458.
    PubMed    


  139. HEROLD KC, Bundy BN, Long SA, Bluestone JA, et al
    An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes.
    N Engl J Med. 2019 Jun 9. doi: 10.1056/NEJMoa1902226.
    PubMed     Abstract available


  140. BRAUN DA, Henderson GV, Sax PE, Miller AL, et al
    A Disturbing Decline.
    N Engl J Med. 2019;380:2257-2262.
    PubMed    


    May 2019
  141. ARVIKAR SL, Schoenfeld SR, Fox AS, Tanguturi VK, et al
    Case 17-2019: A 44-Year-Old Man with Joint Pain, Weight Loss, and Chest Pain.
    N Engl J Med. 2019;380:2157-2167.
    PubMed    


  142. BRAUN DA, Simchowitz B, Henderson GV, Sax PE, et al
    A Disturbing Decline.
    N Engl J Med. 2019;380:e42.
    PubMed    


  143. DE LA FUENTE J, Bird J
    Coronary Arteritis in IgG4-Related Disease.
    N Engl J Med. 2019;380:2156.
    PubMed    


  144. IEZZONI LI
    Dangers of Diagnostic Overshadowing.
    N Engl J Med. 2019;380:2092-2093.
    PubMed    


  145. MONTALBAN X, Arnold DL, Weber MS, Staikov I, et al
    Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple Sclerosis.
    N Engl J Med. 2019 May 10. doi: 10.1056/NEJMoa1901981.
    PubMed     Abstract available


    April 2019
  146. ROGERS KK
    Diabetes and Disclosure.
    N Engl J Med. 2019;380:1495-1497.
    PubMed    


    March 2019
  147. HENDERSON CM, Fink SL, Bassyouni H, Argiropoulos B, et al
    Vitamin D-Binding Protein Deficiency and Homozygous Deletion of the GC Gene.
    N Engl J Med. 2019;380:1150-1157.
    PubMed     Abstract available


    December 2018
  148. SEIKRIT C, Ronco P, Debiec H
    Factor H Autoantibodies and Membranous Nephropathy.
    N Engl J Med. 2018;379:2479-2481.
    PubMed    


  149. LEFEBVRE DR, Reinshagen KL, Yoon MK, Stone JH, et al
    Case 39-2018: An 18-Year-Old Man with Diplopia and Proptosis of the Left Eye.
    N Engl J Med. 2018;379:2452-2461.
    PubMed    


  150. RICE GI, Meyzer C, Bouazza N, Hully M, et al
    Reverse-Transcriptase Inhibitors in the Aicardi-Goutieres Syndrome
    N Engl J Med. 2018;379:2275-7.
    PubMed    


    November 2018
  151. MARCHAND L
    Closed-Loop Insulin for Glycemic Control in Noncritical Care.
    N Engl J Med. 2018;379:1970.
    PubMed    


  152. LAL A, Katta SR, Trivedi N
    Closed-Loop Insulin for Glycemic Control in Noncritical Care.
    N Engl J Med. 2018;379:1970.
    PubMed    


  153. BALLY L, Thabit H, Hovorka R
    Closed-Loop Insulin for Glycemic Control in Noncritical Care.
    N Engl J Med. 2018;379:1970-1971.
    PubMed    


  154. DOWNING NS, McMullan CJ, Rennke HG, Levy BD, et al
    Complements from the Lung.
    N Engl J Med. 2018;379:1767-1773.
    PubMed    


    September 2018
  155. LACKNER KJ, MullerCalleja N
    Diagnosis and Management of the Antiphospholipid Syndrome.
    N Engl J Med. 2018;379:1290.
    PubMed    


  156. RIERA-MESTRE A, Vidaller A
    Diagnosis and Management of the Antiphospholipid Syndrome.
    N Engl J Med. 2018;379:1289-90.
    PubMed    


  157. CIAVARELLA A, Martinelli I
    Diagnosis and Management of the Antiphospholipid Syndrome.
    N Engl J Med. 2018;379:1289.
    PubMed    



  158. Diagnosis and Management of the Antiphospholipid Syndrome.
    N Engl J Med. 2018;379:1289-1290.
    PubMed    


  159. MANDAL J, Margaretten M
    Tuberculosis of the Finger.
    N Engl J Med. 2018;379:1161.
    PubMed    


  160. ANTEL J
    Therapy in Multiple Sclerosis - Coming of Age.
    N Engl J Med. 2018;379:1085-1086.
    PubMed    


  161. CHITNIS T, Arnold DL, Banwell B, Bruck W, et al
    Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple Sclerosis.
    N Engl J Med. 2018;379:1017-1027.
    PubMed     Abstract available


    August 2018
  162. FOX RJ, Coffey CS, Conwit R, Cudkowicz ME, et al
    Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis.
    N Engl J Med. 2018;379:846-855.
    PubMed     Abstract available


  163. GORMAN MP, Gombolay GY, Mehan WA Jr, Thibert RL, et al
    Case 27-2018: A 3-Year-Old Boy with Seizures.
    N Engl J Med. 2018;379:870-878.
    PubMed    


  164. FALK RJ, Husseini JS, Fenves AZ, Rosales IA, et al
    Case 24-2018: A 71-Year-Old Man with Acute Renal Failure and Hematuria.
    N Engl J Med. 2018;379:568-578.
    PubMed    


    June 2018
  165. SEPE V, Velluzzi F, Songini M
    Autoimmune Polyendocrine Syndromes.
    N Engl J Med. 2018;378:2543.
    PubMed    


  166. YANAI H
    Autoimmune Polyendocrine Syndromes.
    N Engl J Med. 2018;378:2542-3.
    PubMed    


  167. TRUFFAUT L, Lefebvre P
    Tongue Necrosis in Giant-Cell Arteritis.
    N Engl J Med. 2018;378:2517.
    PubMed    



  168. Autoimmune Polyendocrine Syndromes.
    N Engl J Med. 2018;378:2542-2544.
    PubMed    


  169. ROSENBAUM JT, Silverman GJ
    The Microbiome and Systemic Lupus Erythematosus.
    N Engl J Med. 2018;378:2236-2237.
    PubMed    


    May 2018
  170. MORRIS CA, Patel MJ, Fenves AZ, Masia R, et al
    Case 17-2018: A 40-Year-Old Woman with Leg Swelling and Abdominal Distention and Pain.
    N Engl J Med. 2018;378:2124-2132.
    PubMed    


  171. GARCIA D, Erkan D
    Diagnosis and Management of the Antiphospholipid Syndrome.
    N Engl J Med. 2018;378:2010-2021.
    PubMed    


    March 2018
  172. HUSEBYE ES, Anderson MS, Kampe O
    Autoimmune Polyendocrine Syndromes.
    N Engl J Med. 2018;378:1132-1141.
    PubMed    


  173. KHOO TK, Olson KM
    Effects of Sotagliflozin Added to Insulin in Type 1 Diabetes.
    N Engl J Med. 2018;378:967.
    PubMed    


  174. DOUMAS M, Imprialos KP, Stavropoulos K
    Effects of Sotagliflozin Added to Insulin in Type 1 Diabetes.
    N Engl J Med. 2018;378:967.
    PubMed    


  175. CONTE C, Secchi A, Napoli N
    Effects of Sotagliflozin Added to Insulin in Type 1 Diabetes.
    N Engl J Med. 2018;378:966.
    PubMed    


  176. GOGTAY NJ, Bose D, Thatte UM
    Effects of Sotagliflozin Added to Insulin in Type 1 Diabetes.
    N Engl J Med. 2018;378:966.
    PubMed    



  177. Effects of Sotagliflozin Added to Insulin in Type 1 Diabetes.
    N Engl J Med. 2018;378:966-968.
    PubMed    


  178. DALMAU J, Graus F
    Antibody-Mediated Encephalitis.
    N Engl J Med. 2018;378:840-851.
    PubMed    


  179. CASEY JD, Englert JA, Katz JT, Miller AL, et al
    An Unexpected Expectoration.
    N Engl J Med. 2018;378:853-858.
    PubMed    


    February 2018
  180. KNUESEL SJ, Guseh JS 2nd, Karp Leaf R, Ciaranello AL, et al
    Case 6-2018: A 35-Year-Old Woman with Headache, Subjective Fever, and Anemia.
    N Engl J Med. 2018;378:753-760.
    PubMed    


  181. FLYNN JT
    ACE Inhibitors and Statins in Adolescents with Type 1 Diabetes.
    N Engl J Med. 2018;378:580.
    PubMed    


  182. MEI ZB, Xiao Y
    ACE Inhibitors and Statins in Adolescents with Type 1 Diabetes.
    N Engl J Med. 2018;378:579.
    PubMed    


  183. JONNALAGADDA VG, Metety VK
    ACE Inhibitors and Statins in Adolescents with Type 1 Diabetes.
    N Engl J Med. 2018;378:579.
    PubMed    



  184. ACE Inhibitors and Statins in Adolescents with Type 1 Diabetes.
    N Engl J Med. 2018;378:579-581.
    PubMed    


    January 2018
  185. CESTARI DM, Cunnane ME, Rizzo JF 3rd, Stone JH, et al
    Case 2-2018. A 41-Year-Old Woman with Vision Disturbances and Headache.
    N Engl J Med. 2018;378:282-289.
    PubMed    


  186. REICH DS, Lucchinetti CF, Calabresi PA
    Multiple Sclerosis.
    N Engl J Med. 2018;378:169-180.
    PubMed    


    December 2017
  187. KELLY NP, Gerhard-Herman M, Desai AS, Miller AL, et al
    An Unusual Cause of Leg Pain.
    N Engl J Med. 2017;377:2267-2272.
    PubMed    


    November 2017
  188. GHIASI M
    Strawberry Gingivitis in Granulomatosis with Polyangiitis.
    N Engl J Med. 2017;377:2073.
    PubMed    


  189. KELLY NP, Vaidya A, Gerhard-Herman M, Desai AS, et al
    An Unusual Cause of Leg Pain.
    N Engl J Med. 2017;377:e29.
    PubMed    


  190. MARCOVECCHIO ML, Chiesa ST, Bond S, Daneman D, et al
    ACE Inhibitors and Statins in Adolescents with Type 1 Diabetes.
    N Engl J Med. 2017;377:1733-1745.
    PubMed     Abstract available


    October 2017
  191. PALAMARA K, Nagarur A, Fintelmann FJ, Kohler MJ, et al
    Case 32-2017. A 64-Year-Old Man with Dyspnea, Wheezing, Headache, Cough, and Night Sweats.
    N Engl J Med. 2017;377:1569-1578.
    PubMed    


  192. AKIYAMA M
    Trial of Tocilizumab in Giant-Cell Arteritis.
    N Engl J Med. 2017;377:1493-4.
    PubMed    


  193. GONZALES-GAY MA, Loricera J, Blanco R
    Trial of Tocilizumab in Giant-Cell Arteritis.
    N Engl J Med. 2017;377:1493.
    PubMed    


  194. STONE JH, Klearman M, Collinson N
    Trial of Tocilizumab in Giant-Cell Arteritis.
    N Engl J Med. 2017;377:1494-1495.
    PubMed    



  195. Trial of Tocilizumab in Giant-Cell Arteritis.
    N Engl J Med. 2017;377:1493.
    PubMed    


  196. ROSENBAUM JT
    Celiac Disease and Autoimmunity - The Missing Ingredient.
    N Engl J Med. 2017;377:1489-1490.
    PubMed    


    September 2017
  197. BHATTACHARYYA RP, Flores EJ, Azar MM
    Case 30-2017. A 65-Year-Old Woman with Altered Mental Status, Bacteremia, and Acute Liver Failure.
    N Engl J Med. 2017;377:1274-1282.
    PubMed    


  198. NATHAN DM
    Adjunctive Treatments for Type 1 Diabetes.
    N Engl J Med. 2017 Sep 13. doi: 10.1056/NEJMe1711296.
    PubMed    


  199. GARG SK, Henry RR, Banks P, Buse JB, et al
    Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes.
    N Engl J Med. 2017 Sep 13. doi: 10.1056/NEJMoa1708337.
    PubMed     Abstract available


  200. RUSH RP, Saltman AP, Prica AA, Breiner A, et al
    Connecting the Dots.
    N Engl J Med. 2017;377:978-984.
    PubMed    


    August 2017
  201. PENG S, Sun X, Sun M
    Adalimumab for Uveitis in Juvenile Idiopathic Arthritis.
    N Engl J Med. 2017;377:789.
    PubMed    



  202. Adalimumab for Uveitis in Juvenile Idiopathic Arthritis.
    N Engl J Med. 2017;377:789-790.
    PubMed    


  203. METZ LM, Eliasziw M
    Trial of Minocycline in Clinically Isolated Syndrome of Multiple Sclerosis.
    N Engl J Med. 2017;377:789.
    PubMed    



  204. Trial of Minocycline in Clinically Isolated Syndrome of Multiple Sclerosis.
    N Engl J Med. 2017;377:788-789.
    PubMed    


  205. DIVAKARAN S, Dellaripa P, Kobzik L, Levy B, et al
    All That Wheezes....
    N Engl J Med. 2017;377:477-484.
    PubMed    


    July 2017
  206. HALLER M, Atkinson M, Schatz D
    More on Intralymphatic Injection of Autoantigen in Type 1 Diabetes.
    N Engl J Med. 2017;377:403.
    PubMed    


  207. HELLMANN DB
    Giant-Cell Arteritis - More Ecstasy, Less Agony.
    N Engl J Med. 2017;377:385-386.
    PubMed    



  208. More on Intralymphatic Injection of Autoantigen in Type 1 Diabetes.
    N Engl J Med. 2017;377:403-5.
    PubMed    


  209. STONE JH, Tuckwell K, Dimonaco S, Klearman M, et al
    Trial of Tocilizumab in Giant-Cell Arteritis.
    N Engl J Med. 2017;377:317-328.
    PubMed     Abstract available



  210. Intralymphatic Injection of Autoantigen in Type 1 Diabetes.
    N Engl J Med. 2017;377:405.
    PubMed    


  211. DIVAKARAN S, Vaidya A, Kobzik L, Dellaripa P, et al
    All That Wheezes...
    N Engl J Med. 2017;377:e6.
    PubMed    



  212. Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002-2012.
    N Engl J Med. 2017;377:301.
    PubMed    


  213. MARTINEZ-CERON E, Garcia-Rio F
    Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes.
    N Engl J Med. 2017;377:300.
    PubMed    



  214. Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002-2012.
    N Engl J Med. 2017;377:301.
    PubMed    


  215. NATHAN DM, Bebu I, Lachin JM
    Frequency of Evidence-Based Screening for Diabetic Retinopathy.
    N Engl J Med. 2017;377:195.
    PubMed    



  216. Frequency of Evidence-Based Screening for Diabetic Retinopathy.
    N Engl J Med. 2017;377:194-195.
    PubMed    


  217. KUMAR S, Sharma VK
    Unmasking Ptosis in Both Eyes.
    N Engl J Med. 2017;377:e1.
    PubMed    


    June 2017
  218. XIA Z, Friedlander RM
    Minocycline in Multiple Sclerosis - Compelling Results but Too Early to Tell.
    N Engl J Med. 2017;376:2191-2193.
    PubMed    


  219. METZ LM, Li DKB, Traboulsee AL, Duquette P, et al
    Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis.
    N Engl J Med. 2017;376:2122-2133.
    PubMed     Abstract available


    May 2017
  220. ESFAHANI K, Miller WH Jr
    Reversal of Autoimmune Toxicity and Loss of Tumor Response by Interleukin-17 Blockade.
    N Engl J Med. 2017;376:1989-91.
    PubMed    


  221. WECHSLER ME, Akuthota P, Jayne D, Khoury P, et al
    Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis.
    N Engl J Med. 2017;376:1921-1932.
    PubMed     Abstract available


  222. DJUKANOVIC R, O'Byrne PM
    Targeting Eosinophils in Eosinophilic Granulomatosis with Polyangiitis.
    N Engl J Med. 2017;376:1985-1986.
    PubMed    


  223. BAIDAL DA, Ricordi C, Berman DM, Alvarez A, et al
    Bioengineering of an Intraabdominal Endocrine Pancreas.
    N Engl J Med. 2017;376:1887-1889.
    PubMed    



  224. Randomized Trial of Thymectomy in Myasthenia Gravis.
    N Engl J Med. 2017 May 4. doi: 10.1056/NEJMx170003.
    PubMed    


  225. SMITH TJ, Kahaly GJ, Ezra DG, Fleming JC, et al
    Teprotumumab for Thyroid-Associated Ophthalmopathy.
    N Engl J Med. 2017;376:1748-1761.
    PubMed     Abstract available


  226. RAMSEY BW, Nepom GT, Lonial S
    Academic, Foundation, and Industry Collaboration in Finding New Therapies.
    N Engl J Med. 2017;376:1762-1769.
    PubMed    


    April 2017
  227. DEISENHAMMER F, Auer M, Hegen H
    Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis.
    N Engl J Med. 2017;376:1693-4.
    PubMed    


  228. MILDINER S, Malnick S
    Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis.
    N Engl J Med. 2017;376:1692-3.
    PubMed    


  229. SHARP MK
    Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis.
    N Engl J Med. 2017;376:1692.
    PubMed    


  230. STERI M, Orru V, Idda ML, Pitzalis M, et al
    Overexpression of the Cytokine BAFF and Autoimmunity Risk.
    N Engl J Med. 2017;376:1615-1626.
    PubMed     Abstract available


  231. KORN T, Oukka M
    A BAFFling Association between Malaria Resistance and the Risk of Multiple Sclerosis.
    N Engl J Med. 2017;376:1680-1681.
    PubMed    


  232. MONTALBAN X, Belachew S, Wolinsky JS
    Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis.
    N Engl J Med. 2017;376:1694.
    PubMed    


  233. SCHOERGENHOFER C, Jilma B
    Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis.
    N Engl J Med. 2017;376:1693.
    PubMed    


  234. HAUSER SL, Belachew Sh, Kappos L
    Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis.
    N Engl J Med. 2017;376:1694.
    PubMed    


  235. RAMANAN AV, Dick AD, Jones AP, McKay A, et al
    Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis.
    N Engl J Med. 2017;376:1637-1646.
    PubMed     Abstract available


  236. THORNE JE
    Adalimumab in the Treatment of Uveitis in Juvenile Idiopathic Arthritis.
    N Engl J Med. 2017;376:1682-1683.
    PubMed    



  237. Frequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes.
    N Engl J Med. 2017;376:1507-1516.
    PubMed     Abstract available


  238. INGELFINGER JR, Jarcho JA
    Increase in the Incidence of Diabetes and Its Implications.
    N Engl J Med. 2017;376:1473-1474.
    PubMed    


  239. MAYER-DAVIS EJ, Lawrence JM, Dabelea D, Divers J, et al
    Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002-2012.
    N Engl J Med. 2017;376:1419-1429.
    PubMed     Abstract available


  240. RAWSHANI A, Rawshani A, Franzen S, Eliasson B, et al
    Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes.
    N Engl J Med. 2017;376:1407-1418.
    PubMed     Abstract available


  241. LAVERY K, Gilden DJ, Saint S, Judson MA, et al
    A Bare-Bones Approach.
    N Engl J Med. 2017;376:1371-1376.
    PubMed    


  242. BEIGNEUX AP, Miyashita K, Ploug M, Blom DJ, et al
    Autoantibodies against GPIHBP1 as a Cause of Hypertriglyceridemia.
    N Engl J Med. 2017 Apr 5. doi: 10.1056/NEJMoa1611930.
    PubMed     Abstract available


    March 2017
  243. MIRANDA S, Reid DK, John ChS
    Myasthenia Gravis.
    N Engl J Med. 2017;376:e25.
    PubMed    


  244. PRIOLA AM, Veltri A, Priola SM
    Myasthenia Gravis.
    N Engl J Med. 2017;376:e25.
    PubMed    


  245. INDRARATNA P, Matar W
    Myasthenia Gravis.
    N Engl J Med. 2017;376:e25.
    PubMed    


  246. GILHUS NE
    Myasthenia Gravis.
    N Engl J Med. 2017;376:e25.
    PubMed    


  247. DE OLIVEIRA WK, Carmo EH, Henriques CM, Coelho G, et al
    Zika Virus Infection and Associated Neurologic Disorders in Brazil.
    N Engl J Med. 2017 Mar 29. doi: 10.1056/NEJMc1608612.
    PubMed    


  248. NAGARUR A, Axelrod L, Dighe AS
    Case 9-2017. A 27-Year-Old Woman with Nausea, Vomiting, Confusion, and Hyponatremia.
    N Engl J Med. 2017;376:1159-1167.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: